BURBANK, CA--(Marketwire - Jul 27, 2011) - Imaging3T, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, today announced that they will soon be completing the first phase of the FDA resubmission strategy.